Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery
Key facts
- Who runs it
- University of British Columbia
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- Sept 2025
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.
- Routine post-operative management and standard delirium reduction measures.
- Record updated
- 3 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Planned open-heart cardiac surgery (e.g. coronary artery bypass grafting, valve replacement surgery)
- Able to understand study procedures and provide informed consent in English
- At least one delirium risk factor: 1) Age less than 65yrs; 2) History of delirium; 3) History of stroke/TIA; 4) Known cognitive impairment; 5) Depression requiring medication
Who cannot take part
- Severe pre-existing cognitive impairment (Montreal Cognitive Assessment [MOCA6]<10)
- Uncorrected visual impairment
- Significant impairment from psychiatric disease
- Enrolment in another clinical trial which may interfere with the study outcome measures
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if a novel device (MindfulGarden) is beneficial in a population of patients undergoing cardiac surgery. The main questions it aims to answer are:
Read full original descriptionShow less
Is a novel device (MindfulGarden) that uses responsive nature-driven imagery feasible in patients undergoing cardiac surgery? Will use of this device reduce the use of psychotropic medications, improve recovery experience, and improve delirium?
Participants will receive routine post-operative management and standard delirium reduction measures. They will be randomized into two groups where one receives the novel device (MindfulGarden) and the other does not.
The 2 groups in the trial
- Intervention GroupTreatment being tested
Receives the MindfulGarden intervention in addition to routine post-operative management and standard delirium reduction measures.
Treatment: A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.
- Control GroupExisting treatment, for comparison
Participants will receive standard care, which includes routine post-operative care pathways for cardiac surgery, and standard delirium reduction measures.
Treatment: Routine post-operative management and standard delirium reduction measures.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery: A Pilot Randomized Controlled Trial
- Record updated
- 3 July 2025